What is LPCN's health score?

Lipocine Inc. (LPCN) has a TradeApes health score of 48 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LPCN's estimated fair value?

Based on our 5-year discounted cash flow model, Lipocine Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is LPCN undervalued or overvalued?

Our model currently rates LPCN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LPCN... Refresh in a moment for the full analysis.

Lipocine Inc. (LPCN)

Healthcare Inconclusive inconclusive mixed

$2.05

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

70 Healthy

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.